Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Zitong Zhao

Showing results (21-30 of 206) with videos related to

Pageof 21
Sort By:
Journal of Translational Medicine|February 2, 2015
Fighting against kidney diseases with small interfering RNA: opportunities and challengesCheng Yang, Chao Zhang, Zitong Zhao, et al.
Virchows Archiv : an International Journal of Pathology|June 24, 2025
Endometrial assessment for fertility-sparing treatment of young women with early-stage endometrial carcinoma: adaptation of a standardized synoptic reportingZitong Zhao, Joella Xiaohong Ang, Ravichandran Nadarajah, et al.
International Journal of Molecular Sciences|January 21, 2022
Native and Engineered Probiotics: Promising Agents against Related Systemic and Intestinal DiseasesHaokun Shen, Zitong Zhao, Zengjue Zhao, et al.
Zhonghua Yi Xue Za Zhi|August 22, 2014
[Effects of AS1411 on the apoptosis of taxol-resistant lung adenocarcinoma A549 cell]Wei Zhou, Zitong Zhao, Lingyan Liu, et al.
Frontiers in Pharmacology|May 30, 2024
Editorial: Natural products, medicinal foods, herbal medicines, bone metabolism diseases, bone-related tumor diseasesJiyu Han, Xuekun Lv, Zitong Zhao, et al.
Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico|February 10, 2025
USP14 targets FABP5-mediated ferroptosis to promote proliferation and cisplatin resistance of HNSCCJiaxin Qian, Zitong Zhao, Liying Ma, et al.
Frontiers in Bioengineering and Biotechnology|December 22, 2022
Screening for MicroRNA combination with engineered exosomes as a new tool against osteosarcoma in elderly patientsJiyu Han, Zitong Zhao, Yanhong Wang, et al.
Journal of Genetics and Genomics = Yi Chuan Xue Bao|December 9, 2019
RASSF6-TRIM16 axis promotes cell proliferation, migration and invasion in esophageal squamous cell carcinomaLeilei Zheng, Zitong Zhao, Lulu Rong, et al.
Frontiers in Bioengineering and Biotechnology|May 21, 2025
Corrigendum: Screening for MicroRNA combination with engineered exosomes as a new tool against osteosarcoma in elderly patientsJiyu Han, Zitong Zhao, Yanhong Wang, et al.
International Journal of Surgical Pathology|July 22, 2016
Pseudotuberculous Granulomatous PyelitisZitong Zhao, Rui Ming Ong, Chin Hong Goh, et al.
Pageof 21

Showing results (21-30 of 206) with videos related to

Sort By:
Pageof 21
Journal of Translational Medicine|February 2, 2015
Fighting against kidney diseases with small interfering RNA: opportunities and challengesCheng Yang, Chao Zhang, Zitong Zhao, et al.
Virchows Archiv : an International Journal of Pathology|June 24, 2025
Endometrial assessment for fertility-sparing treatment of young women with early-stage endometrial carcinoma: adaptation of a standardized synoptic reportingZitong Zhao, Joella Xiaohong Ang, Ravichandran Nadarajah, et al.
International Journal of Molecular Sciences|January 21, 2022
Native and Engineered Probiotics: Promising Agents against Related Systemic and Intestinal DiseasesHaokun Shen, Zitong Zhao, Zengjue Zhao, et al.
Zhonghua Yi Xue Za Zhi|August 22, 2014
[Effects of AS1411 on the apoptosis of taxol-resistant lung adenocarcinoma A549 cell]Wei Zhou, Zitong Zhao, Lingyan Liu, et al.
Frontiers in Pharmacology|May 30, 2024
Editorial: Natural products, medicinal foods, herbal medicines, bone metabolism diseases, bone-related tumor diseasesJiyu Han, Xuekun Lv, Zitong Zhao, et al.
Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico|February 10, 2025
USP14 targets FABP5-mediated ferroptosis to promote proliferation and cisplatin resistance of HNSCCJiaxin Qian, Zitong Zhao, Liying Ma, et al.
Frontiers in Bioengineering and Biotechnology|December 22, 2022
Screening for MicroRNA combination with engineered exosomes as a new tool against osteosarcoma in elderly patientsJiyu Han, Zitong Zhao, Yanhong Wang, et al.
Journal of Genetics and Genomics = Yi Chuan Xue Bao|December 9, 2019
RASSF6-TRIM16 axis promotes cell proliferation, migration and invasion in esophageal squamous cell carcinomaLeilei Zheng, Zitong Zhao, Lulu Rong, et al.
Frontiers in Bioengineering and Biotechnology|May 21, 2025
Corrigendum: Screening for MicroRNA combination with engineered exosomes as a new tool against osteosarcoma in elderly patientsJiyu Han, Zitong Zhao, Yanhong Wang, et al.
International Journal of Surgical Pathology|July 22, 2016
Pseudotuberculous Granulomatous PyelitisZitong Zhao, Rui Ming Ong, Chin Hong Goh, et al.
Pageof 21